Complete Filing Data
Transcode Therapeutics, Inc. reported Stockholders Equity of $3.24 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Transcode Therapeutics, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Net Income * | -$16.8M | -$18.5M | -$17.6M | -$6.8M | -$2.3M |
| Research And Development Expense | $9.7M | $12.3M | $10.2M | $2.8M | $284.5K |
| Operating Income Loss | -$15.7M | -$19.4M | -$18.6M | -$6.2M | -$726.6K |
| Operating Expenses | $15.7M | $19.4M | $18.6M | $6.2M | $726.6K |
| Nonoperating Income Expense | -$1.1M | $872.4K | $1.1M | -$692.3K | -$1.6M |
| General And Administrative Expense | $6.0M | $7.2M | $8.4M | $3.4M | $442.1K |
| Interest Expense | $26.8K | $55.9K | $32.0K | $95.1K | $394.6K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$4.9M | -$4.3M | -$12.1M | -$2.3M | -$5.2M | -$3.3M | -$5.3M | -$4.3M | -$4.8M | -$4.3M | -$4.7M | -$3.5M | -$2.3M | $2.8M | -$4.5M | -$1.4M | -$127.2K | -$41.3K |
| Research And Development Expense | $3.2M | $2.6M | $2.2M | $1.2M | $3.1M | $1.8M | $3.3M | $3.0M | $2.6M | $3.0M | $2.6M | $1.9M | $992.9K | $211.8K | $263.8K | $53.9K | $75.0K | |
| Operating Income Loss | -$4.6M | -$4.2M | -$3.2M | -$2.2M | -$5.1M | -$3.3M | -$5.3M | -$5.1M | -$4.9M | -$5.0M | -$4.7M | -$3.5M | -$2.4M | -$355.5K | -$449.5K | -$239.5K | -$91.6K | |
| Operating Expenses | $4.6M | $4.2M | $3.2M | $2.2M | $5.1M | $3.3M | $5.3M | $5.1M | $4.9M | $5.0M | $4.7M | $3.5M | $2.4M | $355.5K | $449.5K | $239.5K | $91.6K | |
| Nonoperating Income Expense | -$294.9K | -$55.4K | -$8.9M | -$156.0K | -$76.9K | -$37.8K | $10.3K | $781.3K | $70.8K | $664.0K | $36.1K | $7.4K | $30.2K | $3.1M | -$4.0M | -$1.1M | -$35.6K | |
| General And Administrative Expense | $1.4M | $1.7M | $951.7K | $938.0K | $2.0M | $1.5M | $2.0M | $2.2M | $2.3M | $1.9M | $2.1M | $1.6M | $1.4M | $143.8K | $185.7K | $185.6K | $16.6K | |
| Interest Expense | $114.00 | $10.8K | $4.5K | $9.7K | $17.3K | $7.8K | $13.4K | $333.00 | $42.0K | $52.8K | $280.3K | $35.7K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $3.2M | $20.4M | -$3.4M | -$1.1M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.0M | $20.8M | $828.0K | $204.5K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $3.0M | -$2.2M | -$15.9M | $20.0M | $623.5K | |
| Retained Earnings Accumulated Deficit | -$46.4M | -$27.9M | -$10.3M | -$3.5M | ||
| Prepaid Expense And Other Assets Current | $1.7M | $2.1M | $1.9M | $3.2K | ||
| Liabilities Current | $3.5M | $4.3M | $2.5M | $404.9K | ||
| Liabilities And Stockholders Equity | $5.2M | $7.6M | $22.9M | $1.1M | ||
| Liabilities | $3.5M | $4.3M | $2.5M | $4.5M | ||
| Common Stock Value | $2.00 | $2.00 | $1.3K | $464.00 | ||
| Cash And Cash Equivalents At Carrying Value | $2.8M | $5.0M | $20.8M | $828.0K | ||
| Assets Current | $4.5M | $7.4M | $22.7M | $831.2K | ||
| Assets | $5.2M | $7.6M | $22.9M | $1.1M | ||
| Accounts Payable And Accrued Liabilities Current | $3.1M | $4.3M | $2.5M | $369.2K | ||
| Property Plant And Equipment Net | $120.7K | $208.6K | $206.3K | |||
| Contract With Customer Liability Current | $27.1K | $0.00 | $30.5K | $0.00 | ||
| Operating Lease Right Of Use Asset Amortization Expense | $444.0K | $393.3K | ||||
| Deferred Income Current | ||||||
| Operating Lease Right Of Use Asset | $481.7K | |||||
| Operating Lease Liability Current | $412.3K | |||||
| Interest On Subscription Receivable | $362.00 | $491.00 | ||||
| Grants Receivable Current | $360.2K | |||||
| Liabilities Noncurrent | $38.3K | $4.1M | ||||
| Right Of Use Assets Obtained In Exchange For Operating Lease Liabilities | $875.0K | |||||
| Operating Lease Liability Noncurrent | $38.3K | |||||
| Debt Discounts Associated With Derivative Liabilities Of Convertible Promissory Notes | $304.0K | |||||
| Changes In Fair Value Of Derivative Liability | $867.0K | |||||
| Deferred Costs | $224.2K | |||||
| Convertible Debt Noncurrent | $2.1M | $2.1M | ||||
| Stockholders Equity Note Stock Split Conversion Ratio1 | $0.03 | $0.05 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $1.4M | $6.1M | $10.3M | -$2.0M | $1.7M | $1.3M | $4.6M | $1.6M | $4.4M | $2.1M | -$236.8K | $8.2M | $12.4M | $17.0M | $23.2M | -$5.0M | -$7.8M | -$2.6M | -$1.3M | -$1.2M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $2.8M | $7.4M | $11.6M | $5.8M | $1.9M | $3.4M | $4.9M | $2.8M | $7.5M | $3.6M | $1.6M | $8.8M | $13.4M | $16.9M | $22.5M | $79.6K | $99.0K | $1.1M | $1.3M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $5.8M | $2.1M | -$3.3M | -$4.0M | -$729.1K | ||||||||||||||||
| Retained Earnings Accumulated Deficit | -$84.4M | -$79.6M | -$75.3M | -$63.2M | -$57.3M | -$54.9M | -$49.7M | -$42.3M | -$37.0M | -$32.7M | -$22.7M | -$18.4M | -$13.8M | -$7.5M | -$5.2M | ||||||
| Prepaid Expense And Other Assets Current | $1.7M | $690.8K | $1.2M | $1.3M | $1.7M | $1.0M | $1.8M | $1.9M | $1.3M | $2.7M | $2.3M | $482.4K | $1.8M | $2.7M | $460.7K | ||||||
| Liabilities Current | $3.0M | $1.6M | $2.5M | $2.8M | $2.3M | $3.5M | $2.7M | $5.6M | $3.5M | $5.4M | $3.8M | $1.7M | $1.8M | $2.2M | $1.5M | ||||||
| Liabilities And Stockholders Equity | $5.2M | $8.3M | $13.2M | $7.3M | $3.9M | $4.8M | $7.3M | $10.2M | $5.9M | $5.6M | $12.0M | $14.2M | $18.9M | $25.4M | $1.5M | ||||||
| Liabilities | $3.8M | $2.1M | $2.9M | $9.3M | $2.3M | $3.5M | $2.7M | $5.8M | $3.8M | $5.8M | $3.8M | $1.7M | $1.8M | $2.2M | $6.6M | ||||||
| Common Stock Value | $84.00 | $84.00 | $2.3K | $4.00 | $1.7K | $727.00 | $581.00 | $1.1K | $195.00 | $1.6K | $1.3K | $1.3K | $1.3K | $1.3K | $464.00 | ||||||
| Cash And Cash Equivalents At Carrying Value | $2.8M | $7.4M | $11.6M | $5.8M | $1.9M | $3.4M | $4.9M | $7.5M | $3.6M | $1.6M | $8.8M | $13.4M | $16.9M | $22.5M | $79.6K | ||||||
| Assets Current | $4.8M | $8.2M | $13.0M | $7.1M | $3.6M | $4.4M | $6.7M | $9.4M | $4.9M | $4.3M | $11.6M | $13.9M | $18.6M | $25.2M | $540.2K | ||||||
| Assets | $5.2M | $8.3M | $13.2M | $7.3M | $3.9M | $4.8M | $7.3M | $10.2M | $5.9M | $5.6M | $12.0M | $14.2M | $18.9M | $25.4M | $1.5M | ||||||
| Accounts Payable And Accrued Liabilities Current | $3.0M | $1.6M | $2.5M | $2.7M | $2.1M | $3.3M | $2.4M | $5.1M | $3.0M | $5.1M | $3.7M | $1.7M | $1.8M | $2.0M | $1.2M | ||||||
| Property Plant And Equipment Net | $19.9K | $24.7K | $38.1K | $51.6K | $61.4K | $64.6K | $92.4K | $152.4K | $179.0K | $191.8K | $209.9K | $234.7K | $215.3K | $155.6K | $91.6K | ||||||
| Contract With Customer Liability Current | $0.00 | $0.00 | $0.00 | $25.4K | $0.00 | $0.00 | $25.4K | $54.3K | $81.7K | ||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $37.7K | $109.5K | $70.6K | ||||||||||||||||||
| Deferred Income Current | $23.5K | $23.5K | $23.5K | $30.5K | $220.1K | $251.8K | |||||||||||||||
| Operating Lease Right Of Use Asset | $37.7K | $150.2K | $261.7K | $372.2K | $590.2K | $697.8K | $804.4K | ||||||||||||||
| Operating Lease Liability Current | $38.3K | $152.5K | $227.2K | $339.4K | $404.9K | $397.6K | $390.4K | ||||||||||||||
| Interest On Subscription Receivable | -$128.00 | ||||||||||||||||||||
| Grants Receivable Current | $198.3K | $176.1K | $322.4K | $0.00 | $12.0K | $487.9K | |||||||||||||||
| Liabilities Noncurrent | $832.9K | $553.7K | $392.0K | $6.5M | |||||||||||||||||
| Right Of Use Assets Obtained In Exchange For Operating Lease Liabilities | $875.0K | ||||||||||||||||||||
| Operating Lease Liability Noncurrent | $189.8K | $265.7K | $377.8K | ||||||||||||||||||
| Debt Discounts Associated With Derivative Liabilities Of Convertible Promissory Notes | |||||||||||||||||||||
| Changes In Fair Value Of Derivative Liability | -$3.1M | $3.9M | |||||||||||||||||||
| Deferred Costs | $135.8K | $235.8K | $890.5K | ||||||||||||||||||
| Convertible Debt Noncurrent | |||||||||||||||||||||
| Stockholders Equity Note Stock Split Conversion Ratio1 | $0.04 | $0.03 | $0.03 |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Share Based Compensation | $1.7M | $1.0M | $395.3K | $186.0K | $45.4K |
| Net Cash Provided By Used In Operating Activities | -$13.3M | -$18.1M | -$15.8M | -$5.3M | -$493.0K |
| Net Cash Provided By Used In Financing Activities | $16.4M | $15.9M | $6.0K | $25.5M | $1.1M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$405.6K | -$362.9K | $144.4K | $1.9M | $3.2K |
| Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Increase Decrease In Interest Payable Net | -$343.1K | -$1.3M | $1.8M | $2.3M | $191.3K |
| Payments To Acquire Property Plant And Equipment | $21.8K | $35.6K | $100.9K | $254.8K | |
| Net Cash Provided By Used In Investing Activities | -$21.8K | -$35.6K | -$100.9K | -$251.8K | |
| Increase Decrease In Deferred Revenue | -$1.6K | $27.1K | -$30.5K | $30.5K | |
| Increase Decrease In Grant Receivable | -$360.2K | $360.2K | |||
| Proceeds From Issuance Of Common Stock | $16.4M | $15.9M | |||
| Increase Decrease In Operating Lease Liability | -$412.3K | -$424.4K | |||
| Increase Decrease In Interest Payable Net | $55.6K | $121.7K | |||
| Proceeds From Subscription Receivable | $13.1K | ||||
| Proceeds From Stock Options Exercised | $6.0K | ||||
| Increase Decrease In Deposits Outstanding | $111.9K | ||||
| Proceeds From Convertible Debt | $1.2M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q1 2024 | Q1 2023 | Q1 2022 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|---|---|
| Share Based Compensation | $157.7K | $183.2K | $158.8K | $60.6K | $48.4K | |
| Net Cash Provided By Used In Operating Activities | -$3.1M | -$3.9M | -$4.5M | -$3.9M | -$522.2K | |
| Net Cash Provided By Used In Financing Activities | $8.9M | $6.1M | $1.2M | $6.0K | -$131.6K | |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$129.5K | $112.5K | $673.2K | -$124.2K | $475.6K | |
| Increase Decrease In Accounts Payable And Accrued Liabilities Excluding Increase Decrease In Interest Payable Net | -$198.5K | -$684.5K | $576.0K | -$677.9K | $353.2K | |
| Payments To Acquire Property Plant And Equipment | $3.8K | $12.9K | $30.7K | $75.3K | ||
| Net Cash Provided By Used In Investing Activities | -$3.8K | -$12.9K | -$30.7K | -$75.3K | ||
| Increase Decrease In Deferred Revenue | -$25.4K | -$27.1K | -$7.0K | |||
| Increase Decrease In Grant Receivable | $322.4K | -$360.2K | ||||
| Proceeds From Issuance Of Common Stock | $8.9M | $6.1M | $1.2M | |||
| Increase Decrease In Operating Lease Liability | -$38.3K | -$111.2K | -$106.7K | |||
| Increase Decrease In Interest Payable Net | $33.1K | |||||
| Proceeds From Subscription Receivable | $3.6K | |||||
| Proceeds From Stock Options Exercised | $6.0K | |||||
| Increase Decrease In Deposits Outstanding | $111.9K | |||||
| Proceeds From Convertible Debt |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Diluted EPS * | -$47.14 | -$3.4K | -$1.1K | -$0.81 | -$0.51 |
| Weighted Average Number Of Shares Outstanding Basic | 356.1K | 5.4K | 16.2K | 8.4M | 4.6M |
| Earnings Per Share Basic | $-47.14 | $-3,419.01 | $-1,082.79 | $-0.81 | $-0.51 |
| Weighted Average Number Of Diluted Shares Outstanding | 356.1K | 5.4K | 16.2K | 8.4M | 4.6M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 5.0M | 5.0M | |
| Common Stock Shares Authorized | 290.0M | 290.0M | 290.0M | 20.0M | |
| Common Stock Shares Outstanding | 19.0K | 16.2K | 12.9M | 4.6M | |
| Common Stock Shares Issued | 19.0K | 16.2K | 12.9M | 4.6M | |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 | Q3 2020 | Q2 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$5.82 | -$5.13 | -$2.51 | -$146.06 | -$680.23 | -$21.35 | -$48.44 | -$142.38 | -$259.07 | -$6.61 | -$7.20 | -$0.27 | -$0.20 | $0.51 | -$0.97 | -$0.30 | -$0.03 | ||
| Weighted Average Number Of Shares Outstanding Basic | 833.7K | 833.7K | 4.8M | 15.9K | 7.6K | 155.8K | 109.4K | 30.5K | 18.6K | 648.9K | 648.9K | 13.0M | 11.5M | 4.6M | 4.6M | 4.6M | |||
| Earnings Per Share Basic | $-5.82 | $-5.13 | $-2.51 | $-146.06 | $-680.23 | $-21.35 | $-48.44 | $-142.38 | $-259.07 | $-6.61 | $-7.20 | $-0.27 | $-0.20 | $0.60 | $-0.97 | $-0.03 | |||
| Weighted Average Number Of Diluted Shares Outstanding | 833.7K | 833.7K | 4.8M | 15.9K | 7.6K | 155.8K | 109.4K | 30.5K | 18.6K | 648.9K | 648.9K | 13.0M | 11.5M | 5.4M | 4.6M | 4.6M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||
| Preferred Stock Shares Authorized | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | 10.0M | ||||
| Common Stock Shares Authorized | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | 290.0M | ||||
| Common Stock Shares Outstanding | 833.7K | 833.7K | 23.3M | 36.8K | 17.3M | 7.3M | 5.8M | 10.7M | 2.0M | 15.8M | 13.0M | 13.0M | 13.0M | 12.9M | 4.6M | ||||
| Common Stock Shares Issued | 833.7K | 833.7K | 23.3M | 36.8K | 17.3M | 7.3M | 5.8M | 10.7M | 2.0M | 15.8M | 13.0M | 13.0M | 13.0M | 12.9M | 4.6M | ||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.7M | $1.0M | $395.3K | $186.0K | $45.4K |
| Investment Income Interest | $684.00 | $5.3K | $20.4K | $664.00 | $136.00 |
| Grant Income Other | $524.1K | $923.0K | $1.1M | $278.3K | $0.00 |
| Additional Paid In Capital | $48.1M | $31.1M | $30.7M | $65.9K | |
| Depreciation | $90.9K | $123.5K | $98.6K | $42.5K | |
| Stock Issued During Period Value New Issues | $11.4M | $15.9M | $25.4M | ||
| Interest Paid Net | $16.6K | $32.9K | $37.1K | $17.9K | |
| Stock Issued During Period Shares Stock Options Exercised | 91.00 | 259.0K | |||
| Fair Value Adjustment Of Warrants | $938.7K | $6.1K | $14.9K | ||
| Security Deposit | $111.9K | ||||
| Foreign Currency Transaction Gain Loss Before Tax | -$57.1K | ||||
| Paid In Kind Interest | $39.5K | $272.9K | |||
| Stock Issued During Period Value Stock Options Exercised | $6.0K | ||||
| Underwriting Discounts And Commissions Paid | $2.4M | ||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $5.0M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $134.3K | $131.5K | $157.7K | $204.5K | $1.1M | $183.2K | $392.3K | $175.5K | $158.8K | $105.6K | $98.6K | $60.6K | $64.1K | $34.5K | $48.4K | $31.4K | $699.00 | $698.00 | |||
| Investment Income Interest | $147.00 | $148.00 | $146.00 | $179.00 | $178.00 | $168.00 | $131.00 | $246.00 | $4.8K | $9.0K | $1.3K | $442.00 | $141.00 | $1.00 | $12.00 | $28.00 | $57.00 | ||||
| Grant Income Other | $22.2K | $153.7K | $347.8K | $12.0K | $0.00 | $27.1K | $27.4K | $788.9K | $79.4K | $654.9K | $34.7K | $7.0K | $31.7K | $57.1K | $0.00 | ||||||
| Additional Paid In Capital | $85.8M | $85.7M | $85.6M | $61.2M | $58.9M | $56.3M | $54.3M | $46.8M | $39.1M | $32.4M | $31.0M | $30.9M | $30.8M | $30.7M | $149.1K | ||||||
| Depreciation | $13.4K | $32.2K | $29.6K | $21.6K | $1.3K | ||||||||||||||||
| Stock Issued During Period Value New Issues | $8.9M | $2.4M | $785.2K | $6.1M | $7.3M | $6.5M | $1.2M | $25.4M | |||||||||||||
| Interest Paid Net | $5.7K | $8.3K | $4.4K | ||||||||||||||||||
| Stock Issued During Period Shares Stock Options Exercised | 652.0K | 242.5K | 72.7K | 3.9K | |||||||||||||||||
| Fair Value Adjustment Of Warrants | $279.2K | $161.7K | $9.2M | $1.3K | -$42.3K | $47.1K | $14.2K | ||||||||||||||
| Security Deposit | $111.9K | $111.9K | $111.9K | $111.9K | $111.9K | $111.9K | $111.9K | $111.9K | |||||||||||||
| Foreign Currency Transaction Gain Loss Before Tax | -$32.1K | -$47.5K | -$27.2K | -$157.3K | -$72.6K | -$55.3K | |||||||||||||||
| Paid In Kind Interest | $19.6K | ||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $1.2M | $6.0K | |||||||||||||||||||
| Underwriting Discounts And Commissions Paid | |||||||||||||||||||||
| Stock Issued During Period Value Conversion Of Convertible Securities | $5.0M |
Most recent annual filing with the SEC: April 15, 2025
Data sourced from SEC EDGAR public filings as of August 6, 2026.